TENAX THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for TENAX THERAPEUTICS, INC. (TENX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are TENX insiders buying or selling?
In the last 12 months, TENAX THERAPEUTICS, INC. insiders reported 11 open-market purchases ($5.1M) and 0 sales ($0) — net buying of $5.1M. Since May 2020, Trabud has recorded 19 Form 4 filings for TENX: 19 buys ($5.9M) and 0 sells ($0).
Source: SEC EDGAR Form 4
Key Statistics (May 2020 – Sep 18, 2026)
Total Form 4 filings
19
SEC EDGAR
Insider filers
11
Insider buys (19)
$5.9M
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $5.9M in net buying since May 2020, and $5.1M in net buying over the last 12 months. 6 insider buys in the last 90 days.
Recent TENX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Declan Doogan | Director | Purchase | 53.0K | $1.92 | $101.8K | SEC ↗ |
| Sep 16, 2026 | Christopher Thomas Giordano | CEO | Purchase | 10.8K | $1.85 | $20.1K | SEC ↗ |
| Sep 16, 2026 | Thomas R Staab II | Chief Financial Officer | Purchase | 5.7K | $1.94 | $11.0K | SEC ↗ |
| Sep 8, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Purchase | 900.0K | $1.78 | $1.6M | SEC ↗ |
| Sep 2, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Purchase | 770.3K | $1.79 | $1.4M | SEC ↗ |
| Aug 24, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Purchase | 1.0M | $1.77 | $1.8M | SEC ↗ |
| Dec 10, 2025 | Rich Stuart | Chief Medical Officer | Purchase | 5.0K | $10.16 | $50.8K | SEC ↗ |
| Dec 5, 2025 | Rich Stuart | Chief Medical Officer | Purchase | 5.0K | $9.12 | $45.6K | SEC ↗ |
| Nov 20, 2025 | Christopher Thomas Giordano | CEO | Purchase | 2.6K | $7.68 | $20.0K | SEC ↗ |
| Nov 20, 2025 | Thomas Mcgauley | Interim CFO | Purchase | 8.0K | $7.27 | $58.2K | SEC ↗ |
| Nov 19, 2025 | June Sherie Almenoff | Director | Purchase | 2.0K | $7.50 | $14.9K | SEC ↗ |
| Aug 8, 2024 | PROEHL GERALD T | Director | Purchase | 1.7K | $0.00 | $0 | SEC ↗ |
| Aug 8, 2024 | Michael H. Davidson | Director | Purchase | 2.5K | $0.00 | $0 | SEC ↗ |
| Sep 9, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 32.0K | $1.42 | $45.5K | SEC ↗ |
| Sep 3, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 86.0K | $1.43 | $123.2K | SEC ↗ |
| Aug 31, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 32.0K | $1.47 | $47.0K | SEC ↗ |
| Aug 26, 2020 | Steven Boyd | 10% Owner | Purchase | 34.9K | $1.51 | $52.7K | SEC ↗ |
| Aug 21, 2020 | Steven Boyd | Director, 10% Owner | Purchase | 311.5K | $1.48 | $460.4K | SEC ↗ |
| May 19, 2020 | Ronald R Blanck | Director | Purchase | 5.0K | $0.95 | $4.8K | SEC ↗ |
Showing the 19 most recent of 19 Form 4 filings for TENAX THERAPEUTICS, INC..
Most active TENX insiders
- Steven Boyd5 filings
- ADAR1 Capital Management, LLC3 filings
- Christopher Thomas Giordano2 filings
- Rich Stuart2 filings
- Declan Doogan1 filing
Ask anything about TENX insider activity
Use Trabud's AI agent to query TENAX THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me TENX CEO purchases this year" or compare it against any other ticker.
Open the AI agentTENX insider trading FAQ
Are TENAX THERAPEUTICS, INC. insiders buying or selling?
In the last 12 months, TENAX THERAPEUTICS, INC. insiders reported 11 open-market purchases ($5.1M) and 0 sales ($0) — net buying of $5.1M. Since May 2020, Trabud has recorded 19 Form 4 filings for TENX: 19 buys ($5.9M) and 0 sells ($0). Over the full record that is net buying of $5.9M.
How many insiders trade TENX stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TENAX THERAPEUTICS, INC.. The most recent filing was accepted on Sep 18, 2026.
Where does Trabud get TENX insider trading data?
All TENX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.